We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals

149 hedge funds and large institutions have $2.48B invested in Ironwood Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 39

23% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $10.4M

7.5% more ownership

Funds ownership: 131.45%138.95% (+7.5%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

11% less funds holding

Funds holding: 167149 (-18)

11% less capital invested

Capital invested by funds: $2.78B → $2.48B (-$305M)

54% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 28

Holders
149
Holders Change
-18
Holders Change %
-10.78%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
13
Increased
63
Reduced
39
Closed
28
Calls
$12.9M
Puts
$10.4M
Net Calls
+$2.44M
Net Calls Change
+$1.38M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
76
Principal Financial Group
Iowa
$1.39M -$37.1K -2,699 -2%
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
$1.39M
ProShare Advisors
78
ProShare Advisors
Maryland
$1.35M +$75.8K +5,510 +6%
AIM
79
Alambic Investment Management
California
$1.3M +$327K +23,761 +32%
Ameriprise
80
Ameriprise
Minnesota
$1.2M -$27.5K -2,000 -2%
First Trust Advisors
81
First Trust Advisors
Illinois
$1.2M -$309K -22,471 -20%
PPA
82
Parametric Portfolio Associates
Washington
$1.02M +$13.3K +966 +1%
VOYA Investment Management
83
VOYA Investment Management
Georgia
$995K
Bank of Montreal
84
Bank of Montreal
Ontario, Canada
$962K -$91.8K -6,672 -8%
IBT
85
International Biotechnology Trust
United Kingdom
$930K
VEA
86
Virtus ETF Advisers
New York
$920K
CCMH
87
Cornerstone Capital Management Holdings
New York
$880K -$67.4K -4,895 -7%
DekaBank Deutsche Girozentrale
88
DekaBank Deutsche Girozentrale
Germany
$879K
Legal & General Group
89
Legal & General Group
United Kingdom
$879K +$130K +9,473 +17%
UBS Group
90
UBS Group
Switzerland
$807K +$635K +46,134 +309%
SBSB
91
Sullivan, Bruyette, Speros & Blaney
Virginia
$584K
GAM
92
Gotham Asset Management
New York
$541K -$2.34M -170,312 -81%
OC
93
Oppenheimer & Co
New York
$536K +$59.1K +4,298 +12%
TAM
94
Tocqueville Asset Management
New York
$467K
Public Employees Retirement Association of Colorado
95
Public Employees Retirement Association of Colorado
Colorado
$458K
SG Americas Securities
96
SG Americas Securities
New York
$445K +$255K +18,513 +122%
AQR Capital Management
97
AQR Capital Management
Connecticut
$434K -$453K -32,893 -50%
SGAM
98
Smith Group Asset Management
Texas
$432K
VFA
99
Virtus Fund Advisers
Connecticut
$395K -$163K -11,829 -28%
OAM
100
Oppenheimer Asset Management
New York
$369K +$90.8K +6,600 +31%

IRWD Hedge Fund Activity: Q3 2017 in Review

149 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2017, worth a combined $2.48B — down 11% from $2.78B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of IRWD and 13 opened new positions — a net loss of 15 holders — while 39 trimmed existing stakes and 63 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $46.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $15.9M sold.

  • 149 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2017, down from 167 in Q2 2017.
  • Funds reported $2.48B of Ironwood Pharmaceuticals stock for Q3 2017, down 11% quarter-over-quarter.
  • 13 funds opened new Ironwood Pharmaceuticals positions in Q3 2017 and 28 closed out, a net change of -15 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2017 was BVF Inc, an estimated $46.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2017 was Point72 Asset Management, an estimated $15.9M sold.

Based on aggregated 13F filings for Q3 2017.